Regarding the vaccine for the new coronavirus, the UK Government's advisory board has announced that it recommends people under the age of 40 to be vaccinated with another company's vaccine instead of AstraZeneca.
While it is a precautionary measure against the very small risk of blood clots, the benefits of vaccination outweigh the risks for most people.
An advisory committee of the British government announced on the 7th that it recommends that people under the age of 40 be vaccinated with another company's vaccine instead of the vaccine developed by AstraZeneca and others.
Previously, we recommended similar content for people under the age of 30, but this time we have raised the target age by 10 years.
The advisory board said it was a precautionary measure against the very small risk of blood clots after vaccination, and that the vaccine could be secured over the next few months.
Meanwhile, the advisory board reiterated that thrombosis and other events with AstraZeneca vaccines are extremely rare, and emphasized that "for most people, the benefits of preventing aggravation and death far outweigh all risks." I am.
In Europe, there are moves to refrain from vaccination of the younger generation in response to reports of cases of thrombosis confirmed after vaccination with AstraZeneca vaccine.